Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial.
Saved in:
| Title: | Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial. |
|---|---|
| Authors: | Hall A; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Croft J; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK., Walker K; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Boyd K; The Royal Marsden Hospital, London, UK., Roberts S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Holroyd A; The Institute of Cancer Research, London, UK., Garg M; Leicester Royal Infirmary, Leicester, UK., Ferris E; The Institute of Cancer Research, London, UK., Cook G; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.; National Institute for Health and Care Research Leeds Biomedical Research Centre, Leeds, UK., Pierceall WE; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA., Thakurta A; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA., Gandhi A; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA., Pawlyn C; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK., Brown SR; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK., Kaiser M; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK. |
| Source: | British journal of haematology [Br J Haematol] 2026 Jun 16. Date of Electronic Publication: 2026 Jun 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42299497 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hall+A%22">Hall A</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Croft+J%22">Croft J</searchLink>; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Walker+K%22">Walker K</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Boyd+K%22">Boyd K</searchLink>; The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Roberts+S%22">Roberts S</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Holroyd+A%22">Holroyd A</searchLink>; The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Garg+M%22">Garg M</searchLink>; Leicester Royal Infirmary, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Ferris+E%22">Ferris E</searchLink>; The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.; National Institute for Health and Care Research Leeds Biomedical Research Centre, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Pierceall+WE%22">Pierceall WE</searchLink>; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Thakurta+A%22">Thakurta A</searchLink>; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Gandhi+A%22">Gandhi A</searchLink>; Translational Development and Diagnostics, Celgene Corporation, Summit, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Pawlyn+C%22">Pawlyn C</searchLink>; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Brown+SR%22">Brown SR</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Kaiser+M%22">Kaiser M</searchLink>; The Institute of Cancer Research, London, UK.; The Royal Marsden Hospital, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2026 Jun 16. <i>Date of Electronic Publication: </i>2026 Jun 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42299497 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.70611 Languages: – Code: eng Text: English Titles: – TitleFull: Clinical and immunological effects of adding cyclophosphamide to pomalidomide-dexamethasone in relapsed-refractory multiple myeloma: The randomized MUKseven trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hall A – PersonEntity: Name: NameFull: Croft J – PersonEntity: Name: NameFull: Walker K – PersonEntity: Name: NameFull: Boyd K – PersonEntity: Name: NameFull: Roberts S – PersonEntity: Name: NameFull: Holroyd A – PersonEntity: Name: NameFull: Garg M – PersonEntity: Name: NameFull: Ferris E – PersonEntity: Name: NameFull: Cook G – PersonEntity: Name: NameFull: Pierceall WE – PersonEntity: Name: NameFull: Thakurta A – PersonEntity: Name: NameFull: Gandhi A – PersonEntity: Name: NameFull: Pawlyn C – PersonEntity: Name: NameFull: Brown SR – PersonEntity: Name: NameFull: Kaiser M IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 06 Text: 2026 Jun 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1365-2141 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |
